Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people starting semaglutide experience at least one side effect in the first few weeks, and the most common ones — nausea, loose stools, fatigue — are manageable with a few straightforward adjustments. They are also usually temporary. Wegovy (semaglutide) is a prescription-only medicine; a GPhC-registered prescriber will have reviewed your suitability before treatment began, and that clinical relationship matters whenever side effects need discussion. This page covers what the evidence says, what tends to help, and when a symptom needs medical attention.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most persistent misconception our prescribers hear is that side effects signal the wrong treatment. In reality, the gastrointestinal response to semaglutide is a direct consequence of how it works. GLP-1 receptor agonists slow gastric emptying and signal satiety to the brain; the digestive system notices that. Nausea in the early weeks is not a sign of failure, it is, frustratingly, often a sign that the medicine is doing exactly what it should.
What the evidence actually shows is that side effect severity is strongly linked to dose escalation speed and meal choices rather than to any underlying incompatibility. People who eat smaller, lower-fat meals and allow each dose level to settle before moving up tend to report noticeably milder symptoms. Some people experience very few side effects at all, and the reasons for that variation are not fully understood.
The structured titration schedule (starting at 0.25mg and stepping up roughly every four weeks) exists precisely to reduce the severity of GI symptoms. A prescriber who rushes that ladder is not doing you a favour. At nume, dose increases are reviewed clinically each time, not rubber-stamped.
The practical changes that make the most difference are unglamorous: smaller meals, eaten slowly, with less fat per sitting. High-fat foods slow gastric emptying further; on top of semaglutide, that combination tends to worsen nausea and reflux. A portion that would have been normal before treatment can feel overwhelming now, and the instinct to push through rarely ends well.
Timing matters too. Some people find keeping their pen in the fridge door and injecting on the same evening each week (just before the last small meal of the day) means any peak nausea hits during sleep rather than the working day. That is not a clinical recommendation, just a practical pattern some patients find helpful.
Ginger (tea, biscuits, capsules) has modest evidence behind it for nausea relief; cold or room-temperature foods are often better tolerated than hot ones; carbonated drinks tend to worsen bloating. If nausea is significantly disrupting daily life, a prescriber may discuss anti-nausea medication as a short-term option, our nausea-specific guide covers that in detail. Constipation responds well to increased fluid intake, fibre-rich foods and regular movement; a pharmacist can also advise on suitable over-the-counter options.
Semaglutide and caffeine are worth a mention separately: coffee on an empty stomach during the early weeks can amplify nausea. What happens when you combine Wegovy and coffee is a question our prescribers field regularly, and the answer matters for morning routines.
Most side effects on Wegovy are mild and self-limiting. A few are not. Know the difference before you need it.
Seek urgent medical attention for: severe stomach pain that does not ease, especially if it radiates to the back and is accompanied by vomiting, this may indicate pancreatitis, which the MHRA highlighted in its January 2026 Drug Safety Update for GLP-1 medicines. Also seek urgent help for signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing), significant dehydration after persistent vomiting or diarrhoea, or gallbladder symptoms such as sudden severe pain under the right ribs.
Contact your prescriber or GP if: nausea or diarrhoea is still significant two to three weeks after a dose increase; you are struggling to eat or drink enough to maintain hydration; you notice low mood or thoughts that worry you; or you have any symptoms that feel unusual or persistent. If you are a nume patient, our aftercare team is available seven days a week for exactly these conversations, that support is included, not an add-on.
Do not stop treatment abruptly without speaking to your prescriber first. If you have concerns about whether Wegovy suits you at all, that is a clinical question worth discussing properly, not a reason to simply stop the pen. You can also report any suspected side effect to the MHRA using the Yellow Card scheme, your report contributes to ongoing safety monitoring for all patients on this medicine.
For most people, the intensity of gastrointestinal side effects reduces significantly after the first month or two, even as doses increase. The body adapts. Appetite suppression tends to persist (which is the point), but nausea, loose stools and fatigue often become background noise rather than foreground problems.
A small proportion of people find side effects persistent enough to reconsider the treatment. People who report no side effects on Wegovy do exist, and understanding why helps set realistic expectations. If symptoms remain disruptive beyond the titration phase, a prescriber can discuss whether the pace of escalation, meal timing or individual factors are contributing.
If you are deciding whether Wegovy is the right option for your circumstances, or you want to compare it with other licensed options, our weight-loss treatment overview is a good starting point. Suitability, side-effect risk and long-term plan are all part of the conversation at consultation. Start your free consultation and our prescribers will work through the detail with you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.